AD |
Alzheimer’s disease |
CNS |
Central nervous system |
BBB |
Blood–brain barrier |
APOE |
Apolipoprotein E |
PSEN |
Presenilin |
APP |
Amyloid precursor protein |
NMDA |
N-methyl-D-aspartate receptor |
NFT |
Neurofibrillary tangles |
CS-NP |
Chitosan nanoparticles |
ChAT |
Choline acetyltransferase |
PIP |
Piperine |
PAMAM |
Poly (amidoamine) |
PVA |
Polyvinyl alcohol |
PLGA |
poly lactic co glycolic acid |
HPMC |
Hydroxypropyl methylcellulose |
i.n |
Intranasal |
i.v |
Intravenous |
NP |
Nanoparticles |
SLN |
Solid lipid nanoparticles |
NLC |
Nanostructured lipid carrier |
Lf-TMC-NP |
Lactoferrin conjugated N-methylated chitosan nanoparticles |
RSLN |
Risperidone solid lipid nanoparticles |
PDI |
Polydispersibility Index |
EE |
Entrapment efficiency |
BuChE |
Butyrylcholinesterases |
AChEI |
Acetylcholinesterase inhibitor |
ROS |
Reactive oxygen species |
ARIA |
Amyloid-related imaging abnormality |
FDC |
Fixed dose combination |
OLE |
Open label extension |
PET |
Photon emission topography |
PEG |
Polytheylene glycol |
AMT |
Adsorption mediated transcytosis |
Tg |
Glass transition temperature |
PLGA |
Polylactide-co-glycolide |
LNP |
Lipid nanoparticles |
MOF |
Metal organic framework |
MDA |
Malonyldialdehyde |
IVIVC |
In vitro in vivo correlation |
RHT |
Rivastigmine |
TNF |
Tumour necrosis factor |
ELISA |
Enzyme-linked immunosorbent assay |
TRAIL |
TNF-related apoptosis-inducing ligand |
mi-RNA |
Micro ribonucleic acid |
PLA |
Polylactic acid |
AuNP |
Gold nanoparticles |
SPION |
Super paramagnetic iron oxide nanoparticles |
HAS |
Hydroxy-α-sanshool |
GH |
Galantamine hydroxide |
OVAL |
Ovalalbumin |
AUC |
Area under the curve |
SNF |
Simulated nasal fluid |
ACSF |
Artificial cerebrospinal fluid |
PBS |
Phosphate buffer saline |
DPPH |
2,2-diphenyl-1-picrylhydrazyl |
FRAP |
Ferric reducing ability of plasma |
NE |
Nanoemulsion |
GQR |
G alpha subunits |
DTE |
Drug transport efficiency |
DTP |
Drug targeting potential |
MPP |
1-Methyl-4-phenylpyridinium |
QD |
Quantum dots |
WGA |
Wheat germ agglutinin |
ApoE4 |
Apolipoprotein E4 |
GQD |
Graphene quantum dots |
FTIR |
Fourier transform infrared spectroscopy |
HPLC |
High-performance liquid chromatography |
Cmax |
Maximum concentration |
EMA |
European Medicines Agency |
NBCD |
Non-biological complex drugs |
IND |
Investigational new drug |
Aβ42 |
42-amino acidβ amyloid |